Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / Gonioscopy Still Matters
Glaucoma Latest News

ASCRS 2026: Gonioscopy Still Matters

At the ASCRS Subspecialty Day, Ramya Swamy, MD explained that, despite advances in imaging, direct visualization of the angle remains central to care

4/14/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Clinical Report: Gonioscopy Still Matters

Overview

Gonioscopy remains a critical examination technique in glaucoma care, providing direct visualization of the iridocorneal angle, which newer imaging technologies cannot replicate. Despite its importance, gonioscopy is underutilized, with significant gaps in documentation and performance among clinicians.

Background

The role of gonioscopy in glaucoma management is essential, as it allows for direct assessment of angle structures crucial for diagnosis and treatment planning. While advanced imaging technologies like anterior-segment OCT and ultrasound biomicroscopy have emerged, they do not replace the need for gonioscopy. Understanding the limitations and complementary nature of these technologies is vital for optimal patient care.

Data Highlights

Only 49% of Medicare patients had documented gonioscopy prior to glaucoma surgery. More than 70% of patients lack documented gonioscopy within the first 6 months of evaluation.

Key Findings

Rephrase findings for clarity and ensure they are directly supported by the source.

Clinical Implications

Clinicians should prioritize gonioscopy in glaucoma evaluations to ensure comprehensive assessment of the anterior chamber angle. Training and documentation practices must improve to enhance the consistency of gonioscopy performance in clinical settings.

Conclusion

Gonioscopy continues to play a vital role in glaucoma management, and its integration with advanced imaging technologies can enhance patient outcomes. A renewed focus on this technique is essential for effective glaucoma care.

References

  1. Jim Gallagher, Glaucoma Physician, 2026 -- Gonioscopy Still Matters
  2. Jill Gottehrer, Optometric Management, 2025 -- Getting Back to Gonioscopy
  3. European Glaucoma Society, British Journal of Ophthalmology -- Terminology and guidelines for glaucoma, 6th Edition
  4. Comparison of Swept-Source Anterior Segment Ocular Coherence Tomography and Gonioscopy in Detecting Anterior Chamber Angle Closure - PMC
  5. Optometric Management — Getting Back to Gonioscopy
  6. glaucoma physician — Pearls for Using Different Gonioscopy Viewing Systems
  7. European Glaucoma Society – Terminology and guidelines for glaucoma, 6th Edition | British Journal of Ophthalmology
  8. Comparison of Swept-Source Anterior Segment Ocular Coherence Tomography and Gonioscopy in Detecting Anterior Chamber Angle Closure - PMC
  9. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial - ScienceDirect

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: